Molecular Insight appoints CFO


August 16, 2007 -- Molecular Insight Pharmaceuticals of Cambridge, MA has appointed a new chief financial officer.

Donald Wallroth joins Molecular Insight from the national life sciences practice of Tatum, an executive financial services company. Prior to his work at Tatum, Wallroth was a partner at Keen Partners, an investment banking firm with a focus on life sciences.

He has also served as chief operating officer of GoldK and chief financial officer and chief operating officer at Transition Systems, a healthcare software company.

By AuntMinnie.com staff writers
August 16, 2007

Molecular Insight posts Q2 2007 results, August 13, 2007

Copyright © 2007 AuntMinnie.com

 

To read this and get access to all of the exclusive content on AuntMinnie.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnie.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking
account: